We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

EZPW:NASDAQEZCORP, Inc. Analysis

Data as of 2026-08-01 - not real-time

$29.77

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

EZCORP (EZPW) has delivered a **45.9% revenue surge** and improved margins (gross 58.6%, operating 15.2%) while trading at a **PE of 16.1**, well below the industry average of 18.1, giving it a **37% upside** to the median 12‑month target of $40. Recent news highlights strong pawn loan growth, strategic acquisitions and margin expansion, which have powered a **65.8% share rally** against a declining industry backdrop. However, the stock sits **below its 20‑day (31.9) and 50‑day (32.2) SMAs**, with a **bearish MACD** and **RSI at 40.9**, indicating short‑term momentum weakness and a **support level near $28.43**. Volume is trending down, and the 30‑day volatility is high at **52.6%**, suggesting price swings may persist.
Given the solid fundamentals, attractive valuation relative to peers, and a sizable upside to the $40‑plus target, the medium‑ to long‑term outlook remains positive, though investors should monitor regulatory pressures on pawn lending and the company’s ability to sustain growth amid cost headwinds.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Bearish MACD and price below short‑term moving averages
  • Decreasing volume and high 30‑day volatility
  • Proximity to support at $28.43 limiting immediate upside

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • Robust revenue growth (45.9%) and expanding margins
  • Acquisition and store‑expansion tailwinds
  • Target price upside of ~37% with fair valuation multiples

Long Term

> 3 years
Positive
Model confidence: 7/10

Key Factors

  • Sustained pawn loan demand across U.S. and Latin America
  • Strong cash generation despite modest free cash flow
  • Manageable debt profile (Debt/Equity 70%) and solid ROE (14.8%)

Key Metrics & Analysis

Financial Health

Revenue Growth45.90%
Profit Margin9.93%
P/E Ratio16.1
ROE14.76%
ROA6.42%
Debt/Equity70.08
P/B Ratio1.6
Op. Cash Flow$173.7M
Free Cash Flow$1.7M
Industry P/E18.0

Technical Analysis

TrendNeutral
RSI40.9
Support$28.43
Resistance$36.63
MA 20$31.91
MA 50$32.18
MA 200$25.84
MACDBearish
VolumeDecreasing
Fear & Greed Index92.88

Valuation

Target Price$40.80
Upside/Downside37.05%
GradeUndervalued
TypeGrowth

Risk Assessment

Beta1.21
Volatility52.59%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.